Lake Hills Wealth Management LLC Buys Shares of 23,426 Oscar Health, Inc. $OSCR

Key Points

• Lake Hills Wealth Management LLC acquired 23,426 shares of Oscar Health, Inc., valued at approximately $502,000, in the second quarter, reflecting growing interest from institutional investors.
• Oscar Health reported a negative EPS of ($0.89) for the last quarter, beating expectations slightly, but had a year-over-year revenue increase of 29% to $2.86 billion.
• Several brokerages have downgraded Oscar Health's stock rating, with a consensus rating of "Strong Sell" and a price target averaging $12.07, indicating cautious sentiment among analysts.

Lake Hills Wealth Management LLC bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 23,426 shares of the company's stock, valued at approximately $502,000.

A number of other large investors also recently modified their holdings of OSCR. BNP Paribas Financial Markets bought a new position in shares of Oscar Health in the fourth quarter valued at approximately $590,000. Cetera Investment Advisers increased its position in Oscar Health by 17.1% in the fourth quarter. Cetera Investment Advisers now owns 27,066 shares of the company's stock worth $364,000 after buying an additional 3,961 shares during the last quarter. Deutsche Bank AG lifted its position in shares of Oscar Health by 51.2% during the fourth quarter. Deutsche Bank AG now owns 172,127 shares of the company's stock worth $2,313,000 after acquiring an additional 58,282 shares in the last quarter. Nuveen Asset Management LLC lifted its position in shares of Oscar Health by 1.0% during the fourth quarter. Nuveen Asset Management LLC now owns 2,356,298 shares of the company's stock worth $31,669,000 after acquiring an additional 23,237 shares in the last quarter. Finally, ProShare Advisors LLC lifted its position in shares of Oscar Health by 52.7% during the fourth quarter. ProShare Advisors LLC now owns 56,098 shares of the company's stock worth $754,000 after acquiring an additional 19,356 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

Analyst Ratings Changes

OSCR has been the topic of a number of recent analyst reports. Wells Fargo & Company downgraded Oscar Health from an "equal weight" rating to an "underweight" rating and lowered their price objective for the stock from $16.00 to $10.00 in a research report on Friday, July 11th. Piper Sandler reduced their price objective on Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. UBS Group reissued a "sell" rating and issued a $11.00 target price (down from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Robert W. Baird restated a "neutral" rating and issued a $14.00 price objective (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Finally, Baird R W cut Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Four analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Strong Sell" and an average target price of $12.07.

Oscar Health Price Performance

OSCR stock traded down $0.14 during trading on Friday, reaching $18.97. The company's stock had a trading volume of 17,336,897 shares, compared to its average volume of 16,224,456. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $4.90 billion, a P/E ratio of -23.42 and a beta of 1.87. The company's fifty day moving average is $16.19 and its 200-day moving average is $15.26.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. The firm had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The business's quarterly revenue was up 29.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.20 earnings per share. On average, research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.